Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Share Dealing

18 Jun 2013 15:55

RNS Number : 3243H
WANdisco Plc
18 June 2013
 



 

18 June 2013

 

WANdisco plc

 

("WANdisco" or the "Company")

 

Share Dealing

 

Sheffield, UK - WANdisco (LSE: WAND), a provider of high-availability software for global enterprises to meet the challenges of Big Data and distributed software development, announces on 18 June 2013 the following directors sold ordinary shares of £0.10 in the Company ("Ordinary Shares"):

 

·; David Richards, Chairman and Chief Executive Officer of the Company, sold 600,000 Ordinary Shares at a price of 810 pence per share net of commissions. Following this transaction David Richards is interested in 2,783,153 Ordinary Shares representing 13.0 per cent. of the Company's issued share capital.

 

·; James Campigli, Chief Marketing Officer and COO of the Company, sold 300,000 Ordinary Shares at a price of 810 pence per share net of commissions. Following this transaction James Campigli is interested in 1,544,143 Ordinary Shares representing 7.2 per cent. of the Company's issued share capital.

 

In addition, the Company has been notified that Yeturu Aahlad, Chief Scientist, sold 600,000 Ordinary Shares at a price of 810 pence per share net of commissions. Following this transaction Yeturu Aahlad is interested in 2,825,091 Ordinary Shares representing 13.2 per cent. of the Company's issued share capital.

 

Senior management continue to hold a significant interest in WANdisco Ordinary Shares.

 

 

PDMR/Director

Holding pre share sale

% holding pre sale

Sale shares

Holding post share sale

% Holding post Sale

David Richards

3,383,153

15.8

600,000

2,783,153

13.0

James Campigli

1,844,143

8.6

300,000

1,544,143

7.2

Yeturu Aahlad

3,425,091

16.0

600,000

2,825,091

13.2

 

Ends

For further information please contact:

WANdisco plc via FTI Consulting

David Richards, Chairman and Chief Executive Officer

Nick Parker, Chief Financial Officer

 

FTI Consulting +44 (0)20 7831 3113

Matt Dixon / Sophie McMillan / Jon Snowball

 

Panmure Gordon & Co. +44 (0)20 7886 2500

Fred Walsh / Grishma Patel / Ben Roberts (Investment Banking)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZVLFFXQFEBBL
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.